| Literature DB >> 33562065 |
Francesco Fisicaro1, Giuseppe Lanza2,3, Manuela Pennisi1, Carla Vagli4, Mariagiovanna Cantone5, Giovanni Pennisi2, Raffaele Ferri3, Rita Bella4.
Abstract
To date, interest in the role of coffee intake in the occurrence and course of age-related neurological and neuropsychiatric disorders has provided an inconclusive effect. Moreover, no study has evaluated mocha coffee consumption in subjects with mild vascular cognitive impairment and late-onset depression. We assessed the association between different quantities of mocha coffee intake over the last year and cognitive and mood performance in a homogeneous sample of 300 non-demented elderly Italian subjects with subcortical ischemic vascular disease. Mini Mental State Examination (MMSE), Stroop Colour-Word Interference Test (Stroop T), 17-items Hamilton Depression Rating Scalfe (HDRS), Activities of Daily Living (ADL), and Instrumental ADL were the outcome measures. MMSE, HDRS, and Stroop T were independently and significantly associated with coffee consumption, i.e., better scores with increasing intake. At the post-hoc analyses, it was found that the group with a moderate intake (two cups/day) had similar values compared to the heavy drinkers (≥three cups/day), with the exception of MMSE. Daily mocha coffee intake was associated with higher cognitive and mood status, with a significant dose-response association even with moderate consumption. This might have translational implications for the identification of modifiable factors for vascular dementia and geriatric depression.Entities:
Keywords: caffeine; cerebrovascular disease; coffee consumption; dose-response association; executive dysfunction; geriatric depression
Mesh:
Substances:
Year: 2021 PMID: 33562065 PMCID: PMC7916014 DOI: 10.3390/nu13020536
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717